Mar 30, 2026 by Bram BerkowitzFederal Reserve Chair Jerome Powell Just Gave Investors Great NewsPowell spoke earlier today to a class at Harvard University.
Mar 30, 2026 by Jeremy BowmanThe Dow And Nasdaq Have Fallen Into Correction Territory. But Investor Sentiment Has Looked This Gloomy Before -- and Markets RecoveredThe war in Iran is roiling markets, but it's a good time to take a long-term view.
Mar 30, 2026 by Bram BerkowitzBillionaire Investor Bill Ackman Has Some Investing Advice Right Now: Buy the Dip on QualityAckman's investments and advice are closely followed by the market.
Mar 30, 2026 by Harsh ChauhanMicron Just Gave Incredible News to Investors of This AI Infrastructure Stock That Has Tripled in a YearMicron Technology is going to spend more money to meet the strong demand for memory chips, which is great news for this equipment supplier.
Mar 30, 2026 by Jason Hall and Tyler CroweGot $500? 2 Top Growth Stocks to Buy That Could Double Your MoneyDoubling your money could be just the beginning, too.
Mar 30, 2026 by Rich SmithThe Space Sector Is Surging. Should You Buy AST SpaceMobile and Rocket Lab?There's good reason for investors to be nervous about space stocks this week.
Mar 30, 2026 by David Jagielski, CPACould Super Micro Computer's Troubles Sink Nvidia's Stock?Multiple people connected with Super Micro, including its co-founder, have allegedly been smuggling Nvidia's chips to China.
Mar 30, 2026 by David Jagielski, CPADown Around 47% From Its High, Should You Buy Chewy Stock Right Now?The company recently posted some strong earnings numbers.
Mar 30, 2026 by Bram BerkowitzFederal Reserve Chair Jerome Powell Just Gave Investors Great NewsPowell spoke earlier today to a class at Harvard University.
Mar 30, 2026 by Maurie Backman3 Reasons Not Having a Roth IRA in Retirement Could Cost YouYou might sorely regret putting your money elsewhere.
Mar 30, 2026 by Sara AppinoTango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day SurgeThis clinical-stage biotech focused on targeted cancer therapies reported a notable insider sale.
Mar 30, 2026 by Leo Sun3 High-Yield Pipeline Stocks to Buy Now and Hold ForeverEnterprise Products, Energy Transfer, and Enbridge are reliable "toll road" stocks.
Mar 30, 2026 by Rich SmithWhy Does Planet Labs Stock Keep Going Down?Does 4% dilution really justify a 10% sell-off in Planet Labs stock?
Mar 30, 2026 by James BrumleyTesla Grew Sales in Europe for the First Time in a Year. Is the Automaker's Stock Set to Soar in 2026?It's an encouraging headline to be sure. Now consider the rest of the story, while also looking at what's happening outside of Europe.
Mar 30, 2026 by Howard SmithWhy Did Kratos Defense Stock Continue to Slide Today?A path to ending the war with Iran might sour investors on defense names.
Mar 30, 2026 by David Jagielski, CPACould This Artificial Intelligence (AI) Stock Be the Next Palantir?Swarmer's stock recently went public, and it's been a scorching-hot buy out of the gate.
Mar 30, 2026 by Lyle DalyThe No. 1 Crypto Mistake Young Investors MakeCryptocurrency can be worth owning, but be careful how much you buy.
Mar 30, 2026 by Chris NeigerWhy ServiceNow Stock Jumped TodayOptimism in the market and receding AI fears may be driving ServiceNow higher.
Mar 30, 2026 by Neil PatelWorried About Inflation? Take a Look at These 2 Warren Buffett Stocks.In recent years, investors have been thinking more about rising prices across the economy.
Mar 30, 2026 by Dan CaplingerWill This All-Weather ETF Live Up to Its Name?Early performance has been illuminating.
Mar 30, 2026 by Sara AppinoNMI Holdings Executive Sells $756,000 in Shares via Cashless Options ExerciseThis specialty insurer serving U.S. mortgage lenders reported a notable insider sale, as disclosed in recent regulatory filings.
Mar 30, 2026 by Catie HoganIs Oklo Stock a Buy Now?The volatile stock shows significant promise but is still pre-revenue and highly speculative.
Mar 30, 2026 by Robert IzquierdoBicara Therapeutics CEO Sold Over 8,000 Company Shares. Is the Stock a Sell or Buy?This Boston biotech focused on bifunctional cancer therapies reported a notable insider sale amid strong one-year stock gains.
